Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0023418 (leukemia)
 93,477 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

1 1/2 years after diagnosis of acute lymphoblastic leukemia, Hodgkin's disease, stage IIA of cervical lymphnodes could be verified microscopically in a 7 year old girl in continuous complete remission (of leukemia) and was treated with regional irradiation and combination chemotherapy after exploratory laporotomy with splenectomy. The patient now is off therapy, healthy and without any signs of relapse of the two malignancies.
 ...
PMID:[Hodgkin's disease during remission of acute lymphoblastic leukemia (author's transl)]. 26 49

Bone marrow lymphoblasts from 109 children admitted with untreated acute lymphoblastic leukemia (ALL) were tested for spontaneous rosette formation with sheep erythrocytes. Twenty-six children (24%) had lymphoblasts that formed rosettes (E+). Of 13 initial clinical characteristics, 8 were significantly associated with E+ lymphoblasts: mediastinal enlargement (86% of patients E+), leukocyte counts over 100 X 10(9)/liter (65% E+), nodes greater than 2 cm in any diameter (65% E+), age over 5 yr (46% E+), hemoglobin over 8 g/dl (44% E+), hepatomegaly greater than 5 cm (38% E+), boys (35% E+), and lymph node enlargement outside of the cervical area (28% E+). Spleen size, initial platelet counts, and periodic acid-Schiff scores did not distinguish E+ from E- patients. Since few patients were black and few presented with central nervous system leukemia, the association of these two characteristics with E+ blasts could not be determined. A hierarchical classification scheme and a linear logistic regression model were used to define the patterns of characteristics associated with E+ lymphoblasts. The initial clinical characteristics and the poorer course of E+ patients suggest that ALL comprises at least two biologically and clinically distinct types. The E+ ALL may result from a leukemic transformation of a non-Hodgkin lymphoma.
 ...
PMID:Initial prognostic factors and lymphoblast-erythrocyte rosette formation in 109 children with acute lymphoblastic leukemia. 26 81

Creation of an artificial subcutaneous arteriovenous fistula was attempted in five patients with malignant haematological disorders (two with Hodgkin's disease, two with acute lymphatic leukaemia, and one with acute myeloid leukaemia). The average time from the start of treatment to attempted creation of the fistulae was four years. Neither direct arteriovenous anastomosis nor an interposition mandril graft was successful in any patient. Failure was attributed to impaired venous run-off secondary to previous episodes of thrombophlebitis induced by the intravenous administration of cytotoxic drugs. The use of an arteriovenous fistula early in the course of the disease might minimize these later problems.
 ...
PMID:The creation of artificial subcutaneous arteriovenous fistulas in patients with malignant haematological disease. 27 5

Vindesine is a derivative of vinblastine and of vincristine. A high proportion of remissions were obtained in acute lymphoid leukaemia (6 complete and 1 incomplete remissions in 15 patients), in blastic crisis of chronic myeloid leukaemia, and a few responses have been registered in lymphosarcoma and Hodgkin's disease. Permanent 48 h i.v. infusion may include a remission where i.v. pusch of the same dose has failed. The most remarkable characteristic of vindesine is the absence of cross-resistance with vincristine as documented in acute lymphoid leukaemia.
 ...
PMID:[Leukaemias and lymphomas treatment by vindesine. Result of a phase II trial in terms of remission induction (author's transl)]. 27 88

The diseases discussed in this paper include chronic lymphocytic leukemia, monocytic leukemia, chronic granulocytic leukemia, acute leukemias, Hodgkin's disease, and lymphosarcoma. Cutaneous manifestations of these disorders are often sufficiently different to indicate a certain leukemia or lymphoma. The cutaneous manifestations of leukemias and lymphomas may help the clinician suspect the diagnosis.
 ...
PMID:Skin manifestations of leukemias and lymphomas. 27 26

Four male patients with the age from 31--43 years with lymphogranulomatosis and a 23 year old patient with chronic myeloic leukemia developed aseptic necrosis of the femoral head 15 to 69 months after treatment with a combination of cytostatic substances and steroids. In a patient who received maximal prednisone applications aseptic necrosis of the humeral head has been observed also. With increasing life expectancy asceptic bone necrosis due to treatment can appear as a late complication. The early recognition is important. The advancing of this irreversible bone destruction and the associated morbidity can be avoided by immediate cessation of the steroid application. Conservative treatment is indicated.
 ...
PMID:[Aseptic necrosis of the femoral head in lymphogranulomatosis and chronic myeloic leukemia treated intermittently with cytostatic agents and steroids (author's transl)]. 27 39

19 months after the clinical manifestation of acute lymphoblastic leukaemia, Hodgkin's disease, stage Ia, of the cervical lymphnodes developed in a 10 year old girl during continuous complete remission of leukaemia under chemotherapy. After a regional irradiation and after completing the antileukamic therapy the patient is at present off therapy, healthy and without signs of relapse of both malignant systemic diseases. The coincidence of acute lymphoblastic leukaemia in children with other malignant neoplasias is rare. The expected frequency of second malignancies and the theories concerning oncogenesis are shortly reviewed.
 ...
PMID:[Morbus Hodgkin as a second malignancy in acute lymphoblastic leukaemia (author's transl)]. 28 52

28 children with acute lymphoblastic leukaemia and 7 with malignant non-Hodgkin-lymphoma had a computerised tomography (CT) of the brain 2--84 months after the diagnosis was made. The treatment of these children included skull irradiation with a local dose of 1500--2400 R 60Co in the initial therapeutic phase and 4--5 intrathecal methotrexate injections in a dose of 10 mg/m2 body surface per dose during the phase of the skull irradiation. Abnormal CT results were found in 10 children. In some children CT investigations were also performed before the treatment to the CNS began. Abnormal findings before treatment remained unchanged in the follow-up investigations. Thus a large proportion of the abnormalities described had been present before treatment. It appears that pathological changes in the computer tomogram occur in a relatively large number of children after acute lymphoblastic leukaemia and non-Hodgkin-lymphoma, and that most of these changes can be found before CNS treatment. It is unlikely that prophylactic treatment to the CNS can cause pathological changes in the brain detectable by computerised tomography.
 ...
PMID:[Acute lymphoblastic leukaemia and malignant non-Hodgkin-lymphoma in childhood (author's transl)]. 28 57

A patient with Hodgkin's disease is reported in whom 5 years after establishing of diagnosis acute myeloid leukaemia developed during multistage treatment. The patient died. The authors discuss the problem of leukaemia-inducing influence of intensive radiotherapy and chemotherapy.
 ...
PMID:[Acute myeloid leukemia during Hodgkin's disease]. 28 73

T lymphocytes, forming sheep erythrocyte rosettes at 37 degrees C, have been described in thymus glands, mitogen and allogeneic cell stimulated lymphocyte cultures, and acute T cell lymphoblastic leukaemia. This paper describes the finding of such lymphocytes in lymph nodes of a variety of disorders including Hodgkin's disease, Lennert's lymphoma, malignant lymphoma of large transformed T lymphocytes, immunoblastic lymphadenopathy, metastatic carcinoma, and other disorders. A large number of tonsils, but not reactive lymph nodes, also contained a significant number of those T lymphocytes. The significance of these findings in relation to interpretation of immune red cell rosettes and to the subclasses of T lymphocytes is discussed.
 ...
PMID:37 degrees CE rosettes in various malignant and non-malignant disorders. 29 39


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>